Brandy Wilkinson

Company: GemPharmatech

Job title: Chief Executive Officer

Seminars:

Roundtable: Are GEMMs Worth the Investment? Evaluating Their Value in Cancer Research 2:00 pm

Evaluating whether the significant financial and logistical investment in GEMMs yields reliable, actionable insights that justify their use in drug discovery Investigating the gap between GEMM preclinical results and clinical trial outcomes, questioning their true predictive capacity for human patient responses Discussing the evolving role of GEMMs in precision oncology, exploring their potential to refine…Read more

day: Conference Day Two